|
|
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Bivalirudin#Package and Label Display Panel]] |
| {{Bivalirudin}}
| |
| {{CMG}} {{AE}}{{JH}}
| |
|
| |
|
| ==Labels and Packeges==
| | [[Category: Cardiovascular Drugs]] |
| | | [[Category: Drug]] |
| PRINCIPAL DISPLAY PANEL
| | [[Category: Anticoagulants]] |
| | |
| NDC 65293-001-01
| |
| | |
| Angiomax®
| |
| (bivalirudin)
| |
| FOR INJECTION
| |
| | |
| 250 mg
| |
| | |
| For Intravenous Use Only
| |
| Rx Only
| |
| | |
| 10 Single Use Vials<ref>{{Cite web | last = | first = | title = ANGIOMAX (BIVALIRUDIN) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [THE MEDICINES COMPANY] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=911cd48f-01ea-4dec-b30c-95e7e0ea9d2a | publisher = | date = | accessdate = 10 March 2014 }}</ref>
| |
| | |
| {|
| |
| | [[File:Bivalirudin_10.png|thumb|600px]]
| |
| |}
| |
| | |
| {|
| |
| | [[File:Bivalirudin_11.png|thumb|600px]]
| |
| |}
| |
| {|
| |
| | [[File:Bivalirudin_12.png|thumb|600px]]
| |
| |}
| |
| | |
| ==References==
| |
| | |
| {{Reflist}}
| |
| | |
| {{FDA}}
| |
| | |
| [[Category:Cardiovascular Drugs]] | |
| [[Category:Drugs]] | |